Abstract:IntroductionDRIM (Down Regulated in Metastasis Protein) is a protein found to be reduced or lost in metastatic cancer cells and has subsequently been found to be identical to Small Subunit Processome Component (UTP20). It is known to be key to ribosomal RNA (rRNA) processing. However, it is primarily present in the nucleus and cell membrane which suggests to link to gene expression and also membrane related cell function. This strongly suggests that it has an important role to play in cancer cell functions. The present study describes our findings on the expression of DRIM in colorectal cancer and its clinical relevance in disease progression and outcome.MethodsThe DRIM/UTP20 protein was assessed on a human colon tissue array by immunohistochemistry. The DRIM/UTP20 gene transcript was quantitatively analysed by real-time quantitative polymerase chain reaction(RT-PCR) in a cohort of fresh frozen colorectal tumours and matched normal mucosal tissues. The median follow-up period of the cohort was 6 years.ResultsColon tissues were stained strongly for DRIM protein and the staining was largely confined to the cytoplasmic and membrane region of the cells. Normal mucosal cells showed stronger staining than colon cancer cells. Patients who had high levels of DRIM had a significant longer overall survival (OS) (138±9.4 months) than those with low levels (70±13.2 months) (p=0.026), with the survival rate respectively for those with high and low levels at 77.2% and 46.6% during the follow-up period. Likewise, patients with high DRIM levels had a highly significant longer disease-free survival (DFS) compared with those with low levels (p<0.01). The hazard ratios for OS and DFS were respectively 0.332 and 0.272, suggesting a positive predictor of DRIM expression for a favourable overall and disease survival outcome. Although patients who developed distant metastasis had low levels of DRIM compared with those without metastatic diseases, the difference is not statistically significant (p=0.26). When examining the clinical and pathological factors of the patients, it was found that there was a progressive reduction of DRIM from T1 tumours to T4 tumours (p=0.002) and reductions from TNM1 to TNM4 tumours (p=0.031, by ANOVA). Similarly, levels of DRIM in Dukes A tumours (90980±55541 copies) were also higher than Dukes B (40243±22456) and Dukes C (19151±660) tumours. DRIM expression did not correlate with lymph node involvement of this cohort of colorectal cancers.ConclusionDRIM/UTP20 is strongly expressed in colon tissues. The expression levels of this molecule in colon cancer tissues are a favourable factor for the clinical outcome of patients, suggesting a prognostic value of the molecule in colon cancer.

Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer

Clinical Significance of Tertiary Lymphoid Structure Maturity in Colorectal Cancer Patients

Prognostic factors based on histological categorization of desmoplastic reactions in pancreatic cancer

Prognostic scoring system based on indicators reflecting the tumor glandular differentiation and microenvironment for patients with colorectal cancer

Characterisation of colorectal cancer by hierarchical clustering analyses for five stroma-related markers

Desmoplasia influenced recurrence of disease and mortality in stage III colorectal cancer within five years after surgery and adjuvant therapy

Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma

The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations

Prognostic values of tumor-stroma ratio and tumor-infiltrating lymphocytes in stagesⅡandⅢcolorectal cancer

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer

Development and Validation of a Novel Prognostic Nomogram Combined With Desmoplastic Reaction for Synchronous Colorectal Peritoneal Metastasis

Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters

PTH-94 DRIM expression in colorectal cancer and its possible tumour suppressive role, clinical and prognostic significance

Analysis of clinical features and prognostic factors of desmoplastic small round cell tumor

Prognostic Factors for Extra‐abdominal and Abdominal Wall Desmoids: A 20‐year Experience at a Single Institution

Pros and Cons: High Proportion of Stromal Component Indicates Better Prognosis in Patients With Pancreatic Ductal Adenocarcinoma—A Research Based on the Evaluation of Whole-Mount Histological Slides

Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer

Abstract 6180: Tumor microenvironment phenotypes predict recurrence in African Americans diagnosed with colorectal cancer: A comparative study of manual grading with digital pathology

Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

Clinical and prognostic differences between surgically resected right-sided and left-sided colorectal cancer

Histological growth patterns of colorectal cancer liver metastases: a strong prognostic marker associated with invasive patterns of the primary tumor and p53 alteration